Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $946,456 (100.0% shares, 0.0% debt)

Holdings (16)

AXSM AXSOME THERAPEUTICS INC 19.8%

Value ($000) $187,839 Shares 2,360,077 Est. Cost $49.79 Unrealized +34.3%

— IMMUNOGEN INC 18.6%

Value ($000) $175,812 Shares 5,929,592 Est. Cost $18.87 Unrealized —

NUVL NUVALENT INC 15.0%

Value ($000) $141,633 Shares 1,924,626 Est. Cost $22.67 Unrealized +173.0%

APGE APOGEE THERAPEUTICS INC 8.7%

Value ($000) $82,176 Shares 2,941,176 Est. Cost $22.03 Unrealized -9.0%

— RAYZEBIO INC 8.2%

Value ($000) $77,459 Shares 1,245,929 Est. Cost $22.97 Unrealized —

— KINIKSA PHARMACEUTICALS LTD 5.3%

Value ($000) $50,572 Shares 2,883,221 Est. Cost $16.59 Unrealized —

ARGX ARGENX SE 4.5%

Value ($000) $42,952 Shares 112,903 Est. Cost $315.99 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 3.2%

Value ($000) $29,830 Shares 1,369,623 Est. Cost $15.80 Unrealized -0.1%

ELVN ENLIVEN THERAPEUTICS INC 3.1%

Value ($000) $29,498 Shares 2,131,369 Est. Cost $20.33 Unrealized -39.8%

— ASTRIA THERAPEUTICS INC 2.9%

Value ($000) $27,296 Shares 3,554,129 Est. Cost $9.99 Unrealized —

COGT COGENT BIOSCIENCES INC 2.2%

Value ($000) $20,927 Shares 3,558,975 Est. Cost $9.69 Unrealized -20.9%

DNTH DIANTHUS THERAPEUTICS INC 2.1%

Value ($000) $20,056 Shares 1,928,503 Est. Cost $12.62 Unrealized -12.4%

— MERUS N V 2.1%

Value ($000) $19,724 Shares 717,254 Est. Cost $24.17 Unrealized —

TYRA TYRA BIOSCIENCES INC 2.0%

Value ($000) $19,298 Shares 1,393,329 Est. Cost $14.88 Unrealized -13.0%

TERN TERNS PHARMACEUTICALS INC 1.4%

Value ($000) $13,240 Shares 2,040,000 Est. Cost $3.72 Unrealized +42.3%

SYRE SPYRE THERAPEUTICS INC 0.9%

Value ($000) $8,144 Shares 378,421 Est. Cost $13.22 Unrealized +4.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
AXSM	AXSOME THERAPEUTICS INC	2,360,077	$187,839	19.8%	$49.79	+34.3%	COM	05464T104
—	IMMUNOGEN INC	5,929,592	$175,812	18.6%	$18.87	—	COM	45253H101
NUVL	NUVALENT INC	1,924,626	$141,633	15.0%	$22.67	+173.0%	COM	670703107
APGE	APOGEE THERAPEUTICS INC	2,941,176	$82,176	8.7%	$22.03	-9.0%	COM	03770N101
—	RAYZEBIO INC	1,245,929	$77,459	8.2%	$22.97	—	COM	75525N107
—	KINIKSA PHARMACEUTICALS LTD	2,883,221	$50,572	5.3%	$16.59	—	COM CL A	G5269C101
ARGX	ARGENX SE	112,903	$42,952	4.5%	$315.99	—	SPONSORED ADR	04016X101
VRDN	VIRIDIAN THERAPEUTICS INC	1,369,623	$29,830	3.2%	$15.80	-0.1%	COM	92790C104
ELVN	ENLIVEN THERAPEUTICS INC	2,131,369	$29,498	3.1%	$20.33	-39.8%	COM	29337E102
—	ASTRIA THERAPEUTICS INC	3,554,129	$27,296	2.9%	$9.99	—	COM	04635X102
COGT	COGENT BIOSCIENCES INC	3,558,975	$20,927	2.2%	$9.69	-20.9%	COM	19240Q201
DNTH	DIANTHUS THERAPEUTICS INC	1,928,503	$20,056	2.1%	$12.62	-12.4%	COM	252828108
—	MERUS N V	717,254	$19,724	2.1%	$24.17	—	COM	N5749R100
TYRA	TYRA BIOSCIENCES INC	1,393,329	$19,298	2.0%	$14.88	-13.0%	COM	90240B106
TERN	TERNS PHARMACEUTICALS INC	2,040,000	$13,240	1.4%	$3.72	+42.3%	COM	880881107
SYRE	SPYRE THERAPEUTICS INC	378,421	$8,144	0.9%	$13.22	+4.2%	COM NEW	00773J202